3HVT
STRUCTURAL BASIS OF ASYMMETRY IN THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE HETERODIMER
Replaces: 2HVTReplaces: 1HVTExperimental procedure
| Spacegroup name | C 1 2 1 |
| Unit cell lengths | 223.600, 69.900, 105.500 |
| Unit cell angles | 90.00, 106.40, 90.00 |
Refinement procedure
| Resolution | 8.000 - 2.900 |
| R-factor | 0.266 |
| Rwork | 0.266 |
| RMSD bond length | 0.016 |
| RMSD bond angle | 2.500 |
| Phasing software | X-PLOR |
| Refinement software | X-PLOR |
Data quality characteristics
| Overall | |
| High resolution limit [Å] | 2.900 * |
| Rmerge | 0.090 * |
| Number of reflections | 33169 * |
| Completeness [%] | 1.0 * |
Crystallization Reagents in Literatures
| ID | crystal ID | solution | reagent name | concentration (unit) | details |
| 1 | 1 | drop | RT | 6-8 (mg/ml) | |
| 10 | 1 | reservoir | beta-octylglucoside | 0.2 (%(w/v)) | |
| 11 | 1 | reservoir | glycerol | 10 (%(v/v)) | |
| 12 | 1 | reservoir | PEG8000 | 14 (%(w/v)) | |
| 13 | 1 | reservoir | sodium azide | 0.02 (%) | |
| 2 | 1 | drop | Bis-Tris propane | 25 (mM) | |
| 3 | 1 | drop | 50 (mM) | ||
| 4 | 1 | drop | beta-octylglucoside | 0.1 (%(w/v)) | |
| 5 | 1 | drop | glycerol | 5 (%(v/v)) | |
| 6 | 1 | drop | PEG8000 | 7 (%(w/v)) | |
| 7 | 1 | drop | sodium azide | 0.01 (%) | |
| 8 | 1 | reservoir | Bis-Tris propane | 50 (mM) | |
| 9 | 1 | reservoir | 100 (mM) |






